Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Melanoma].

Toshiaki Saida1

  • 1Dept. of Dermatology, Shinshu University School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 13, 2006
PubMed
Summary

Recent advancements in malignant melanoma management include revised TNM staging and surgical techniques like sentinel node biopsy. While adjuvant therapies remain debated, new immunotherapies and targeted treatments show promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The BRAAFF-Annotated Acral Lesions Dataset (BALD): A Curated Set of Dermatoscopic Images of Acral Melanoma and Nevi from Various Sources.

The Journal of investigative dermatology·2025
Same author

Validation of a Dermatoscopy-Based Algorithm for the Diagnosis of Acral Melanoma.

Dermatology (Basel, Switzerland)·2024
Same author

Dermoscopy for Acral Melanocytic Lesions: Revision of the 3-step Algorithm and Refined Definition of the Regular and Irregular Fibrillar Pattern.

Dermatology practical & conceptual·2022
Same author

Stem cell spreading dynamics intrinsically differentiate acral melanomas from nevi.

Cell reports·2021
Same author

ALK-positive atypical Spitz tumour with conspicuous rosette-like structures.

European journal of dermatology : EJD·2021
Same author

[Melanoma and Non‒Melanoma Skin Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2021

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Pathology

Context:

  • Malignant melanoma classification and staging have undergone significant revisions.
  • New clinical guidelines for melanoma management have been recently proposed.
  • Surgical advancements aim to improve patient quality of life.

Purpose:

  • To summarize recent updates in malignant melanoma classification, staging, and management.
  • To highlight advancements in surgical procedures and adjuvant therapies.
  • To discuss emerging trends in immunotherapy and molecular targeting therapy for melanoma.

Summary:

  • The TNM classification and staging system for malignant melanoma have been fundamentally revised.
  • Surgical procedures such as narrow margin excision and sentinel node biopsy are improving patient outcomes.
  • The efficacy of high-dose interferon-alpha as adjuvant therapy is still under investigation, with ongoing research in immunotherapy and molecular targeting.

Impact:

  • Revised staging impacts treatment decisions and prognostic assessments for malignant melanoma patients.
  • Minimally invasive surgical techniques enhance recovery and quality of life.
  • Emerging therapies offer potential for improved treatment efficacy in advanced melanoma.

Related Experiment Videos